Contamination risk may cost trust £50m a year

cancer survivor chemotherapy man patient

A trust could face a £50m yearly bill for outsourcing preparation of chemotherapy drugs, after external inspections raised concern about a leaking roof and other infection risks.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here